Results 151 to 160 of about 8,359,193 (315)

Response to ‘Potential negative economic effects of diuretic lounge’ [PDF]

, 2020
Adam Ioannou, Sofia Metaxa, Amit Mandal, Constantinos G. Missouris   +3 more
openalex   +1 more source

Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study

ESC Heart Failure, Volume 12, Issue 2, Page 1326-1335, April 2025.
Abstract Aims Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with preserved or reduced ejection fraction.
Robin Willixhofer, Mauro Contini, Michele Emdin, Damiano Magrì, Alice Bonomi, Elisabetta Salvioni, Fabrizio Celeste, Alberico Del Torto, Claudio Passino, Christophe D.J. Capelle, Chiara Arzilli, Emiliano Fiori, Nicolò Capra, Christina Kronberger, Nikita Ermolaev, Andreas Kammerlander, Beatrice Musumeci, Giuseppe Vergaro, Vincenzo Castiglione, René Rettl, Giacomo Tini, Andrea Baggiano, Iacopo Fabiani, Susanna Sciomer, Roza Badr Eslam, Piergiuseppe Agostoni   +25 more
wiley   +1 more source

Herbs for horses [PDF]

, 2010
The aim of this study was to find out how many and which of the herbs used for horses that have been scientifically studied with results to justify the use.
Fors, Maria
core   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Response to ‘Thiazide diuretics: rat versus man’ [PDF]

, 2008
Sirirat Reungjui, Richard J. Johnson
openalex   +1 more source

High‐Caloric Realimentation and Mental and Physical Well‐Being in Patients With Extreme Anorexia Nervosa. A Prospective Study

European Eating Disorders Review, EarlyView.
ABSTRACT Objective While high caloric realimentation (HCR) is increasingly recommended for quick weight restoration of patients with anorexia nervosa (AN), the development of AN‐specific psychopathology and somatic symptoms during HCR have so far insufficiently been studied.
Ulrich Voderholzer, Juliane Silbernagl, Verena Haas, Ulrich Cuntz, Silke Naab, Norbert Quadflieg   +5 more
wiley   +1 more source

Tubular resistance to furosemide contributes to the attenuated diuretic response in nephrotic rats. [PDF]

, 1992
K A Kirchner, James R. Voelker, D. Craig Brater   +2 more
openalex   +1 more source

Effects of Day‐Patient Treatment on Eating Disorder Symptoms in Persons With Bulimia Nervosa: A Meta‐Analysis

European Eating Disorders Review, EarlyView.
ABSTRACT Objective Outpatient treatment for bulimia nervosa (BN) often fails to reduce core symptoms like binge eating and purging, while inpatient care is costly and separates patients from their everyday environment. Day‐patient treatment offers a middle ground by providing intensive daytime therapy with the opportunity to apply skills at home.
Anna L. Dieffenbacher, Ulrich Voderholzer, Adrian Meule   +2 more
wiley   +1 more source

Nalfurafine, a G-Protein-Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics. [PDF]

Hypertension, 2022
Meariman JK, Sutphen JC, Gao J, Kapusta DR.   +3 more
europepmc   +1 more source

Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction [PDF]

, 2018
Background Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome that presents clinicians with a diagnostic challenge. The use of natriuretic peptides to exclude a diagnosis of HFpEF has been proposed.
Abbate, Antonio, Arena, Ross, Billingsley, Hayley, Buckley, Leo F., Canada, Justin M., Carbone, Salvatore, Del Buono, Marco G., Kadariya, Dinesh, Trankle, Cory R., Van Tassell, Benjamin W.   +9 more
core   +1 more source